Three-year results of Artisan/Verisyse phakic intraocular lens implantation. Results of the United States Food And Drug Administration clinical trial.

Objective: To assess the safety and efficacy of the Artisan/Verisyse phakic intraocular lens (IOL) for the correction of high myopia.

Design: Prospective, open-label, noncomparative, multicenter clinical trial.

Participants: A total of 684 adults with axial myopia from -4.

Artisan phakic intraocular lens for myopia:short-term results of a prospective, multicenter study.

Purpose: To evaluate the safety and efficiency of the Artisan iris-supported phakic intraocular lens (Ophtec BV, Groningen, Netherlands) for the correction of high myopia.

Study Design: Nonrandomized, prospective, multicenter trial conducted under a United States Food and Drug Administration (FDA) Investigational Device Exemption.

Participants: One hundred fifty-five eyes of 155 patients with myopia from -5.